Home > Journals > Minerva Pediatrica > Past Issues > Minerva Pediatrica 2012 October;64(5) > Minerva Pediatrica 2012 October;64(5):545-7

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA PEDIATRICA

A Journal on Pediatrics, Neonatology, Adolescent Medicine,
Child and Adolescent Psychiatry


Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,532


eTOC

 

CASE REPORTS  


Minerva Pediatrica 2012 October;64(5):545-7

language: English

Dapsone treatment in a girl with severe chronic thrombocytopenic purpura. Does it work? Do not touch it!

Pusiol A., Nocerino A., Passone E., Tenore A.

Pediatric Clinic, Udine University Hospital, Udine, Italy


PDF  


Dapsone has been shown to be effective in treating immune thrombocytopenic purpura (ITP) in adults. In children the experience is limitated. We describe our experience using dapsone in a female with refractory, symptomatic ITP who suffered intracranic haemorrhage and massive gastric bleeding. After treatment platelet counts was more than 100 x 103/μL, and reached 1000x103/μL. Discontinuation resulted in a rapid decrease in platelet counts, with severe intracranial haemorrhage (ICH). The recovery of dapsone led the platelets count to lower values. We suggest that treatment should not be discontinued in responders, at least in children with symptomatic ITP. Additional studies of dapsone in children are warranted.

top of page

Publication History

Cite this article as

Corresponding author e-mail

anna.pusiol@uniud.it